Pfizer retractions point to the need for better research oversight

A vocal advocate for science integrity and reproducibility believes Pfizer’s recent call to retract five cancer research papers should be commended even as the field struggles with irreproducible science. At the same time, it points to the continued need to improve research oversight. 
C. Gle. view full post